Supplementary Table 1 from Targeting PI3K/mTOR Overcomes Resistance to HER2-Targeted Therapy Independent of Feedback Activation of AKT
收藏NIAID Data Ecosystem2026-05-26 收录
数据链接：
官方服务：
资源简介：
XLSX file - 14K, Table S1: Calculated IC50s for the PI3K/mTOR pathway inhibitors against the breast cancer cell line panel. ER: Estrogen Receptor. N/A: IC50 not achieved, N/D: IC50 not determined
创建时间：
2014-07-01
